LITS · LITE STRATEGY INC

Lite Strategy, Inc. a clinical-stage pharmaceutical company, focuses on the development of novel and differentiated therapies for the treatment of cancer. It is also involved in holding Litecoin tokens as a primary reserve asset. The company was formerly known as MEI Pharma, Inc. and changed its name to Lite Strategy, Inc. in September 2025. Lite Strategy, Inc. was incorporated in 2000 and is based in San Diego, California.

9920 Pacific Heights Blvd., San Diego, CA, 92121, United States
Biotechnology
Healthcare

Market Cap

25.6M

52 Wk Range

$0.69 - $2.00

Previous Close

$0.86

Open

$0.85

Volume

267,832

Day Range

$0.76 - $0.85

Enterprise Value

21.31M

Cash

4.281M

Avg Qtr Burn

-2.176M

Insider Ownership

1.40%

Institutional Own.

16.49%

Qtr Updated

Sep 30th 2026